시장보고서
상품코드
2055020

생체재료 시장 : 재료 유형별, 용도별, 기술별, 최종사용자별, 지역별

Biomaterials Market, By Material Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials ), By Application, By Technology, By End User, By Geography

발행일: | 리서치사: 구분자 Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 4,500 금액 안내 화살표 ₩ 7,010,000
PDF & Excel (Multi User License - Up to 7 Users) help
PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 7,000 금액 안내 화살표 ₩ 10,905,000
PDF & Excel (Corporate User License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 금액 안내 화살표 ₩ 15,579,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생체재료 시장은 2026년에 2,415억 5,000만 달러로 추정되며, 2033년에 6,826억 6,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 16.0%로 성장할 것으로 전망됩니다.

보고서 범위 보고서 상세
기준 연도: 2025년 2026년 시장 규모: 2,415억 5,000만 달러
과거 데이터 기간: 2020-2024년 예측 기간: 2026-2033년
2026-2033년까지 예측 기간 CAGR: 16.00% 2033년 시장 규모 예측: 6,826억 6,000만 달러

세계 생체재료 시장은 재료과학, 생명공학, 헬스케어 분야의 혁신이 교차하는 영역에서 급속히 성장하고 있는 분야입니다.

생체재료란 임플란트, 약물전달 시스템, 조직공학용 지지체, 진단 기기 등 의료 분야에서 생체 시스템과 상호작용하도록 설계된 천연 및 합성 물질을 포괄하는 용어입니다. 이러한 재료들은 생체적합성을 갖도록 설계되어 있어, 인체 내에서 유해한 반응을 일으키지 않고 효과적으로 기능할 수 있도록 보장됩니다.

이 시장은 티타늄 합금 등의 금속계 생체재료, 하이드록시아파타이트 등의 세라믹계 생체재료, 생분해성 폴리머를 포함한 고분자계 생체재료, 여러 특성을 결합한 복합재료 등 다양한 범주로 나뉩니다. 만성 질환의 증가, 전 세계적인 고령화, 의료비 상승, 그리고 재료 과학 분야의 지속적인 기술 발전이 이 부문의 눈부신 성장을 이끌고 있습니다.

또한, 나노기술, 3D 프린팅, 스마트 소재의 통합은 생체 재료의 응용 분야에 혁명을 일으키고 있으며, 맞춤형 의료와 재생의료의 실현을 가능하게 하고 있습니다. 이 시장은 병원, 클리닉, 연구 기관, 제약 회사 등 다양한 최종사용자를 대상으로 하며, 그 용도는 정형외과 및 순환기 계통의 임플란트부터 상처 치료 및 조직 재생 솔루션에 이르기까지 다양합니다.

시장 역학

세계 생체재료 시장은 의료의 패러다임을 근본적으로 변화시키고 있는 몇 가지 주요 촉진요인에 의해 주도되고 있습니다. 주요 성장 요인은 급속히 진행되는 세계적 고령화입니다. 고령자는 관절 치환술, 심혈관 임플란트, 치과 임플란트 등 노화에 따른 질환에 대해 더 빈번한 의료적 개입이 필요하기 때문에 의료용 임플란트, 의지, 재생의료 솔루션에 대한 수요가 크게 증가하고 있습니다.

스마트 생체 재료, 생체활성 재료, 나노기술을 활용한 제품 개발을 포함한 재료 과학의 발전은 응용 가능성을 넓히고, 생체적합성과 기능의 향상을 통해 환자의 치료 성과를 개선하고 있습니다.

만성 질환, 생활습관병, 스포츠 손상의 유병률 증가는 다양한 의료 분야에서 첨단 생체 재료 솔루션에 대한 큰 수요를 창출하고 있습니다. 그러나 시장은 성장 궤도를 저해할 수 있는 중대한 제약에 직면해 있습니다. 생체 재료, 특히 신소재나 새로운 용도에 대한 복잡하고 장기적인 규제 승인 절차는 시장 진입의 큰 장벽이 되어 제품의 상용화를 지연시키고 있습니다. 이를 위해서는 광범위한 임상 검사 및 안전성 평가가 필요합니다.

생체 재료에 따른 높은 개발 및 제조 비용에 더해, 엄격한 품질 관리 요건이 특히 개발도상국에서 해당 재료의 접근성과 보급률을 제한하고 있습니다. 또한, 장기적인 생체적합성, 잠재적인 부작용, 생물학적 상호작용의 복잡성에 대한 우려가 지속적인 과제로 남아 있습니다. 이러한 제약이 있음에도 불구하고, 재생의학, 조직공학, 맞춤형 의료 솔루션 분야의 새로운 용도가 등장함에 따라 시장에는 큰 기회가 생겨나고 있습니다.

본 조사의 주요 특징

  • 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
  • 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
  • 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 생체재료 시장의 주요 기업 개요을 작성하였습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략입니다.
  • 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
  • 세계 생체재료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자들은 세계 생체재료 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있습니다.

목차

제1장 조사 목적과 가정

제2장 시장 전망

제3장 시장 역학·규제·동향 분석

제4장 세계의 생체재료 시장 : 재료 유형별, 2021-2033년

제5장 세계의 생체재료 시장 : 용도별, 2021-2033년

제6장 세계의 생체재료 시장 : 기술별, 2021-2033년

제7장 세계의 생체재료 시장 : 최종사용자별, 2021-2033년

제8장 세계의 생체재료 시장 : 지역별, 2021-2033년

제9장 경쟁 구도

제10장 애널리스트의 제안

제11장 참고문헌과 조사 방법

KSM 26.06.18

Biomaterials Market is estimated to be valued at USD 241.55 Bn in 2026 and is expected to reach USD 682.66 Bn by 2033, growing at a compound annual growth rate (CAGR) of 16.0% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 241.55 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 16.00% 2033 Value Projection: USD 682.66 Bn

The global biomaterials market represents a rapidly expanding sector at the intersection of materials science, biotechnology, and healthcare innovation.

Biomaterials encompass a diverse range of natural and synthetic substances designed to interact with biological systems for medical applications, including implants, drug delivery systems, tissue engineering scaffolds, and diagnostic devices. These materials are engineered to be biocompatible, ensuring they can function effectively within the human body without causing adverse reactions.

The market spans various categories including metallic biomaterials like titanium alloys, ceramic biomaterials such as hydroxyapatite, polymeric biomaterials including biodegradable polymers, and composite materials that combine multiple properties. The increasing prevalence of chronic diseases, aging global population, rising healthcare expenditure, and continuous technological advancements in material science are driving significant growth in this sector.

Moreover, the integration of nanotechnology, 3D printing, and smart materials is revolutionizing biomaterial applications, enabling personalized medicine approaches and regenerative therapies. The market serves diverse end-users including hospitals, clinics, research institutions, and pharmaceutical companies, with applications ranging from orthopedic and cardiovascular implants to wound healing and tissue regeneration solutions.

Market Dynamics

The global biomaterials market is propelled by several key drivers that are fundamentally reshaping the healthcare landscape. The primary growth driver is the rapidly aging global population, which significantly increases the demand for medical implants, prosthetics, and regenerative medicine solutions, as elderly individuals require more frequent medical interventions for age-related conditions such as joint replacements, cardiovascular devices, and dental implants.

Technological advancements in material science, including the development of smart biomaterials, bioactive materials, and nanotechnology-enhanced products, are expanding application possibilities and improving patient outcomes through better biocompatibility and functionality.

The increasing prevalence of chronic diseases, lifestyle-related disorders, and sports injuries is creating substantial demand for advanced biomaterial solutions across various medical specialties. However, the market faces significant restraints that could impede growth trajectories. The complex and lengthy regulatory approval processes for biomaterials, particularly for novel materials and applications, create substantial barriers to market entry and delay product commercialization, requiring extensive clinical trials and safety assessments.

High development and manufacturing costs associated with biomaterials, coupled with stringent quality control requirements, limit accessibility and adoption rates, particularly in developing economies. Additionally, concerns regarding long-term biocompatibility, potential adverse reactions, and the complexity of biological interactions pose ongoing challenges. Despite these restraints, the market presents tremendous opportunities driven by emerging applications in regenerative medicine, tissue engineering, and personalized healthcare solutions..

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biomaterials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include BASF SE, Covestro AG, Celanese Corporation, Carpenter Technology Corporation, Royal DSM, Evonik Industries AG, Berkeley Advanced Biomaterials, Cam Bioceramics B.V., Corbion N.V., Lubrizol Corporation, Zimmer Biomet Holdings Inc, Stryker Corporation, Johnson and Johnson, Medtronic PLC, and Boston Scientific Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global biomaterials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biomaterials market

Market Segmentation

  • Material Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Metallic Biomaterials
    • Titanium and Titanium Alloys
    • Cobalt-Chrome Alloys
    • Others
  • Polymeric Biomaterials
    • Polymethyl Methacrylate (PMMA)
    • Polyetheretherketone (PEEK)
    • Others
  • Ceramic Biomaterials
    • Calcium Phosphate
    • Zirconia
    • Others
  • Natural Biomaterials
    • Collagen and Gelatin
    • Hyaluronic Acid
    • Others
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Orthopedic
  • Cardiovascular
  • Dental
  • Plastic Surgery
  • Wound Healing
  • Tissue Engineering
  • Neurological Disorders
  • Ophthalmology
  • Drug Delivery Systems
  • Technology Insights (Revenue, USD Bn, 2021 - 2033)
  • 3D Printing
  • Nanotechnology
  • Electrospinning
  • Bioprinting
  • Hydrogels Technology
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Research Laboratories
  • Biotechnology and Pharmaceutical Companies
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • BASF SE
  • Covestro AG
  • Celanese Corporation
  • Carpenter Technology Corporation
  • Royal DSM
  • Evonik Industries AG
  • Berkeley Advanced Biomaterials
  • Cam Bioceramics B.V.
  • Corbion N.V.
  • Lubrizol Corporation
  • Zimmer Biomet Holdings Inc
  • Stryker Corporation
  • Johnson and Johnson
  • Medtronic PLC
  • Boston Scientific Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Biomaterials Market, By Material Type
    • Global Biomaterials Market, By Application
    • Global Biomaterials Market, By Technology
    • Global Biomaterials Market, By End User
    • Global Biomaterials Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Biomaterials Market, By Material Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Metallic Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Titanium and Titanium Alloys
      • Cobalt-Chrome Alloys
      • Others
  • Polymeric Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Polymethyl Methacrylate (PMMA)
      • Polyetheretherketone (PEEK)
      • Others
  • Ceramic Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Calcium Phosphate
      • Zirconia
      • Others
  • Natural Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Collagen and Gelatin
      • Hyaluronic Acid
      • Others

5. Global Biomaterials Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Plastic Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Wound Healing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ophthalmology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Drug Delivery Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Biomaterials Market, By Technology, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • 3D Printing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Nanotechnology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Electrospinning
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Bioprinting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Hydrogels Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Biomaterials Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Biomaterials Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Covestro AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Celanese Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Carpenter Technology Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Royal DSM
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Evonik Industries AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Berkeley Advanced Biomaterials
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cam Bioceramics B.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Corbion N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lubrizol Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zimmer Biomet Holdings Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson and Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기